期刊文献+

高铁与低铁环境对成骨细胞hFOB1.19膜铁转运蛋白1表达的影响 被引量:1

Expression of ferroportin 1 in cultured osteoblast hFOB1.19 under iron excess and deficiency
下载PDF
导出
摘要 目的观察细胞培养液中加入铁离子或铁离子螯合剂后成骨细胞(hFOB1.19)膜铁转运蛋白1(FPN1)表达的变化,探讨铁离子浓度对成骨细胞FPN1表达的影响。方法将不同浓度的枸橼酸铁铵(FAC,50、100、200μmol/L)和去铁胺(DFO,5、10、20μmol/L)分别加入人hFOB1.19培养基,24h后用共聚焦显微镜(CLSM)测定细胞内铁离子浓度,用定量PCR、Westernblotting和免疫荧光法测定不同组别成骨细胞FPN1的表达并进行统计比较。结果用不同浓度的FAC和DFO干预20h后,成骨细胞内铁离子浓度随FAC浓度增加而增加,随DFO浓度增加而降低,组间差异有统计学意义(P<0.05);FPN1基因和蛋白表达随FAC浓度增加而增加,随DFO浓度增加而降低,组间差异有统计学意义(P<0.05)。结论高铁环境可上调FPN1表达,低铁环境可下调FPN1表达。FPN1表达量的改变可有效维持成骨细胞内铁离子浓度的平衡。 Objective To investigate the effects of iron excess and iron deficiency on the expression of ferroportin 1 (FPN1) in human osteoblast. Methods Human osteoblast cells (hFOB1. 19) were treated with ferric ammonium citrate (FAC) or deferoxamine (DFO) of different concentrations. The intracellular iron ion was measured by a confocal laser scanning microscope ( CLSM ). The expression of FPN1 at mRNA and protein levels was detected with real-time quantitative polymerase chain reaction (PCR) , western blotting and immunofluoreseenee. Results The confocal microcopy measurements showed that the fluorescence intensity representing intracellular iron concentration was significantly weakened with increasing of FAC concentration and enhanced with increasing of DFO ( P 〈 0. 05 ). The real-time PCR, western blotting and immunofluoreseence indicated that the mRNA and protein expression of FPN1 in osteoblast was increased with increasing of FAC in a concentration-dependent manner and decreased with increasing of DFO in a concentration-dependent manner (P 〈 0. 05 ). Conclusion Increasing of intracellular iron ion by the FAC treatment increased the FPN1 expression. In contrast, decreasing intracellular iron ion by the DFO treatment decreased the FNP1 expression. The changes of FPN1 expression may help to maintain the balance of intracelullar iron in osteoblasts.
出处 《中华骨质疏松和骨矿盐疾病杂志》 2012年第4期264-270,共7页 Chinese Journal Of Osteoporosis And Bone Mineral Research
基金 国家自然科学基金(81273090) 江苏省自然科学基金(BK2012608) 江苏省普通高等学校创新计划项目(CXLX_0086) 苏州市科技基础设施建设计划之高技术研究重点实验室资助项目(SZS201208) 苏州市应用基础研究计划之医疗卫生部分资助项目(SZS201002)
关键词 成骨细胞 铁代谢 膜铁转运蛋白 osteoblast iron metabolism ferroportin 1
  • 相关文献

参考文献33

  • 1Yamasaki K, Hagiwara H. Excess iron inhibits osteoblastmetabolism [ J]. Toxicol Lett, 2009, 191 : 211-215.
  • 2Doyard M,Fatih N, Monnier A, et al. Iron excess limitsHHIPL-2 gene expression and decreases osteoblastic activi-ty in human MG-63 cells [ J]. Osteoporos Int, 2012, 23:2435 -2445.
  • 3Messer JG,Kilbarger AK,Erikson KM, et al. Iron over-load alters iron-regulatory genes and proteins, down-regu-lates osteoblastic phenotype,and is associated with apopto-sis in fetal rat calvaria cultures [ J] . Bone,2009,45 :972 -979.
  • 4Pattanapanyasat K, Webster HK, Tongtawe P, et al. Effect oforally active hydroxypyridinone iron chelators on human lym-phocyte function [J]. Br J Haematol, 1992 , 82: 13 -19.
  • 5Messer JG, Cooney PT, Kipp DE. Iron chelator deferoxam-ine alters iron-regulatory genes and proteins and suppressesosteoblast phenotype in fetal rat calvaria cells [ J ] . Bone,2010, 46; 1408 -1415.
  • 6Donovan A, Lima C, Andrews NC. Analysis of iron homeo-stasis in mice with a targeted deletion of the gene encodingthe iron exporter Ferroportin 1 ( Fpnl ) [ J] . Blood,2003,102: 157 -157.
  • 7Ganz T. Cellular iron: ferroportin is the only way out [ J].Cell Metab, 2005, 1: 155 -157.
  • 8Rice AE, Mendez MJ, Hokanson CA, et al. Investigationof the biophysical and cell biological properties of ferroport-in ,a multipass integral membrane protein iron exporter[J]. J Mol Biol, 2009, 386: 717 -732.
  • 9Canonne-Hergaux F, Donovan A, Delaby C, et al. Com-parative studies of duodenal and macrophage ferroportinproteins [ J ] ? Am J Physiol Gastrointest Liver Physiol,2006, 290: 156-163.
  • 10Yang FM, Liu XB, Quinones M, et al. Regulation of re-ticuloendothelial iron transporter MTP1 ( Slclla3) by in-flammation [J ]. J Biol Chem,2002,211 : 39786 -39791.

二级参考文献39

  • 1马勇,徐又佳,王爱东,俞晨,王冰,张鹏,张振东.大鼠骨质疏松模型中肝脏Hepcidin基因表达的初步研究[J].苏州大学学报(医学版),2006,26(3):367-369. 被引量:12
  • 2Huang X. Treatment of osteoporosis in peri- and post-menopausal women with hepcidin. United States Patent Application Publication, Pub. No. : US 2010/0204122 A1.
  • 3Guggenbuhl P, Filmon R, Mabilleau G, et al. Iron inhibits hydyoxyapatite crystal growth in vitro. Metabolism, 2008, 57: 903 -910.
  • 4Yamasaki K, Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicol Lett, 2009, 191:211-215.
  • 5Zarjou A, Jeney V, Arosio P, et al. Ferritin-ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res, 2010, 25: 164-172.
  • 6Tsay J, Yang Z, Ross FP, et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood, 2010, 116:2582-2589.
  • 7Isomura H, Fujie K, Shibata K, et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology, 2004, 197:93-100.
  • 8Kudo H, Suzuki S, Watanabe A, et al. Effects of colloidal iron overload on renal and hepatic siderosis and the femur in male rats. Toxicology, 2008, 246 : 143-147.
  • 9Parelman M, Stoecker B, Baker A, et al. Iron restriction negatively affects bone in female rats and mineralization of hFOB osteoblast cells. Exp Biol Med , 2006, 231:378-386.
  • 10Schnitzler CM, Schnaid E, MaePhail AP, et al. Ascorbic acid deficiency, iron overload and alcohol abuse underlie the severe osteoporosis in black African patients with hip fractures--a bone histomorphometric study. Calcif Tissue Int, 2005, 76:79-89.

共引文献40

同被引文献35

  • 1中国健康促进基金会骨质疏松防治中国白皮书编委会.骨质疏松症中国白皮书.中华健康管理学杂志,2009,3(3):148-156.
  • 2Jian J,Pelle E,Huang X.Iron and menopause::does increased iron affect the health of postmenopausal women?[J] .Antioxid Redox Signal,2009,11:2939-2943.
  • 3Li GF,Pan YZ,Xu YJ,et al.Iron homeostas is in osteoporosis and its clinical implications[J] .Osteoporos Int,2012,23:2403-2408.
  • 4Kim BJ,Ahn SH,Bae SJ,et al.Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men:A 3-year retrospective longitudinal study[J] .J Bone Miner Res,2012,27:2279-2290.
  • 5Jia P,Xu YJ,Zhang ZL,et al.Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species[J] .J Orthop Res,2012,30:1843-1852.
  • 6Imai Y,Kondoh S,Kouzmenko A,et al.Minireview:osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha[J] .Mol Endocrinol,2010,24:877-885.
  • 7Nakamura T,Imai Y,Matsumoto T,et al.Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts[J] .Cell,2007,130:811-823.
  • 8Geng L,Yao Z,Yang H,et al.Association of Ca repeat polymorphism in estrogen receptor beta gene with postmenopausal osteoporosis in Chinese[J] .J Genet Genomics,2007,34:868-876.
  • 9Pantopoulos K,Porwal SK,Tartakoff A,et al.Mechanisms of mammalian iron homeostasis[J] .Biochemistry,2012,51:5705-5724.
  • 10Castillo A,Moreno MI,Grande N,et al.Mutations in the HFE,TFR2,and SLC40A1 genes in patients with hemochromatosis[J] .Gene,2012,508:15-20.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部